Harvard Bioscience Announces First Quarter 2024 Financial Results
May 07, 2024 07:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2024. Jim Green,...
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
April 29, 2024 08:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May...
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
April 09, 2024 09:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing...
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
March 11, 2024 08:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at...
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
March 07, 2024 07:00 ET
|
Harvard Bioscience, Inc.
Q4 Revenues of $28.2 millionQ4 Gross Margin of 58.0% (230 bps year-over-year improvement)Q4 operating income of $0.3 million, adjusted operating income of $3.3 millionStrong operating cash flow...
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
March 06, 2024 08:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology...
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
February 27, 2024 17:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on...
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
November 20, 2023 16:40 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor...
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
November 09, 2023 16:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the...
Harvard Bioscience Announces Third Quarter 2023 Financial Results
November 07, 2023 07:00 ET
|
Harvard Bioscience, Inc.
Q3 Revenues of $25.4 millionQ3 Gross Margin of 58.1%Q3 GAAP operating loss of $0.9 million, adjusted operating income $1.8 millionContinued strong operating cash flow drove debt reduction of $8.3...